Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan W Stewart

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
Journal of Affective Disorders|February 17, 2009
Clinical correlates of the worsening or emergence of suicidal ideation during SSRI treatment of depression: an examination of citalopram in the STAR*D studySidney Zisook, Madhukar H Trivedi, Diane Warden, et al.
Biological Psychiatry|April 22, 2011
Current source density measures of electroencephalographic alpha predict antidepressant treatment responseCraig E Tenke, Jürgen Kayser, Carlye G Manna, et al.
The Journal of Clinical Psychiatry|November 26, 2008
Response to a selective serotonin reuptake inhibitor (citalopram) in major depressive disorder with melancholic features: a STAR*D reportPatrick J McGrath, Ahsan Y Khan, Madhukar H Trivedi, et al.
Focus (American Psychiatric Publishing)|January 31, 2020
Treatment of Maternal Depression in a Medication Clinical Trial and Its Effect on ChildrenMyrna M Weissman, Priya Wickramaratne, Daniel J Pilowsky, et al.
The American Journal of Psychiatry|January 24, 2015
Treatment of maternal depression in a medication clinical trial and its effect on childrenMyrna M Weissman, Priya Wickramaratne, Daniel J Pilowsky, et al.
CNS Spectrums|August 13, 2010
Psychoticism and paranoid ideation in patients with nonpsychotic major depressive disorder: prevalence, response to treatment, and impact on short- and long-term treatment outcomeChristina M Dording, David Mischoulon, Tracie M Goodness, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 5, 2007
Maximizing the adequacy of medication treatment in controlled trials and clinical practice: STAR(*)D measurement-based careMadhukar H Trivedi, A John Rush, Bradley N Gaynes, et al.
The International Journal of Neuropsychopharmacology|April 4, 2009
Do atypical features affect outcome in depressed outpatients treated with citalopram?Jonathan W Stewart, Patrick J McGrath, Maurizio Fava, et al.
Journal of Psychiatric Practice|October 4, 2008
An open pilot study of the combination of escitalopram and bupropion-SR for outpatients with major depressive disorderAndrew F Leuchter, Ira M Lesser, Madhukar H Trivedi, et al.
The American Journal of Psychiatry|September 28, 2007
Effect of age at onset on the course of major depressive disorderSidney Zisook, Ira Lesser, Jonathan W Stewart, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Journal of Affective Disorders|February 17, 2009
Clinical correlates of the worsening or emergence of suicidal ideation during SSRI treatment of depression: an examination of citalopram in the STAR*D studySidney Zisook, Madhukar H Trivedi, Diane Warden, et al.
Biological Psychiatry|April 22, 2011
Current source density measures of electroencephalographic alpha predict antidepressant treatment responseCraig E Tenke, Jürgen Kayser, Carlye G Manna, et al.
The Journal of Clinical Psychiatry|November 26, 2008
Response to a selective serotonin reuptake inhibitor (citalopram) in major depressive disorder with melancholic features: a STAR*D reportPatrick J McGrath, Ahsan Y Khan, Madhukar H Trivedi, et al.
Focus (American Psychiatric Publishing)|January 31, 2020
Treatment of Maternal Depression in a Medication Clinical Trial and Its Effect on ChildrenMyrna M Weissman, Priya Wickramaratne, Daniel J Pilowsky, et al.
The American Journal of Psychiatry|January 24, 2015
Treatment of maternal depression in a medication clinical trial and its effect on childrenMyrna M Weissman, Priya Wickramaratne, Daniel J Pilowsky, et al.
CNS Spectrums|August 13, 2010
Psychoticism and paranoid ideation in patients with nonpsychotic major depressive disorder: prevalence, response to treatment, and impact on short- and long-term treatment outcomeChristina M Dording, David Mischoulon, Tracie M Goodness, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 5, 2007
Maximizing the adequacy of medication treatment in controlled trials and clinical practice: STAR(*)D measurement-based careMadhukar H Trivedi, A John Rush, Bradley N Gaynes, et al.
The International Journal of Neuropsychopharmacology|April 4, 2009
Do atypical features affect outcome in depressed outpatients treated with citalopram?Jonathan W Stewart, Patrick J McGrath, Maurizio Fava, et al.
Journal of Psychiatric Practice|October 4, 2008
An open pilot study of the combination of escitalopram and bupropion-SR for outpatients with major depressive disorderAndrew F Leuchter, Ira M Lesser, Madhukar H Trivedi, et al.
The American Journal of Psychiatry|September 28, 2007
Effect of age at onset on the course of major depressive disorderSidney Zisook, Ira Lesser, Jonathan W Stewart, et al.
Pageof 8